SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Biostage, Inc. (BSTG) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 21/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BSTG
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.42
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-14.49 |
$82K |
$-11.58M |
-14120.7% |
| 2017 |
$-6.63 |
$0.00 |
$-11.92M |
- |
| 2018 |
$-1.69 |
$0.00 |
$-7.53M |
- |
| 2019 |
$-1.20 |
$0.00 |
$-8.33M |
- |
| 2020 |
$-0.55 |
$0.00 |
$-4.87M |
- |
| 2021 |
$-0.74 |
$0.00 |
$-7.98M |
- |
| 2022 |
$-1.09 |
$0.00 |
$-6.07M |
- |
| 2023 |
$-0.67 |
$0.00 |
$-9.02M |
- |
| 2024 |
$-0.52 |
$0.00 |
$-7.73M |
- |
| 2025 |
$-0.42 |
$0.00 |
$-6.87M |
- |
